|
2016 Conference Publication Nutrient deficiencies are common at the time of diagnosing coeliac disease in an Australian cohortShelley, L., Jacobs, A. and Daveson, A. J. M. (2016). Nutrient deficiencies are common at the time of diagnosing coeliac disease in an Australian cohort. HOBOKEN: WILEY-BLACKWELL. |
|
2016 Conference Publication Disaccharidase deficiency at time of diagnosis of coeliac disease, with rates of mucosal healing at surveillance endoscopyShelley, L., Jacobs, A. and Daveson, A. J. M. (2016). Disaccharidase deficiency at time of diagnosis of coeliac disease, with rates of mucosal healing at surveillance endoscopy. HOBOKEN: WILEY-BLACKWELL. |
|
2016 Conference Publication A Single Intradermal (ID) Injection of Nexvax2 (R), a Peptide Composition With Dominant Epitopes for Gluten-Reactive CD4+T Cells, Activates T Cells and Triggers Acute Gastrointestinal Symptoms in HLA-DQ2.5+People With Celiac Disease (CeD)Goel, Gautam, Mayassi, Toufic, Qiao, Shuo-Wang, Ciszewski, Cezary, King, Tim, Daveson, A. J., Andrews, Jane M., Krishnarajah, Janakan, Krause, Richard, Brown, Gregor J., Fogel, Ron, Barish, Charles F., Epstein, Roger, Kinney, Timothy, Miner, Philip B., Tye-Din, Jason A., Girardin, Adam, Goldstein, Kaela, Dzuris, John L., Williams, Leslie J., Xavier, Ramnik, Sollid, Ludvig M., Jabri, Bana and Anderson, Robert P. (2016). A Single Intradermal (ID) Injection of Nexvax2 (R), a Peptide Composition With Dominant Epitopes for Gluten-Reactive CD4+T Cells, Activates T Cells and Triggers Acute Gastrointestinal Symptoms in HLA-DQ2.5+People With Celiac Disease (CeD). 57th Annual Meeting and Residents Fellow Conference of the Society-for-Surgery-of-the-Alimentary-Tract (SSAT) / 52nd Annual Meeting on Digestive Disease Week (DDW) / Meeting of the American-Gastroenterological-Association (AGA), San Diego Ca, May 21-24, 2016. W B SAUNDERS CO-ELSEVIER INC. |
|
2016 Conference Publication A single intradermal (ID) injection of Nexvax (R), a peptide composition with dominant epitopes for gluten-reactive CD4+T Cells, activates T Cells and triggers acute gastrointestinal symptoms in HLA DQ2.5+ People with Celiac Disease (CeD)Goel, G. and Daveson, J. (2016). A single intradermal (ID) injection of Nexvax (R), a peptide composition with dominant epitopes for gluten-reactive CD4+T Cells, activates T Cells and triggers acute gastrointestinal symptoms in HLA DQ2.5+ People with Celiac Disease (CeD). 57th Annual Meeting and Residents Fellow Conference of the Society-for-Surgery-of-the-Alimentary-Tract (SSAT) / 52nd Annual Meeting on Digestive Disease Week (DDW) / Meeting of the American-Gastroenterological-Association (AGA),, San Diego, CA, United States, 21-24 May 2016. |
|
2016 Conference Publication Demyelination during infliximab therapy for crown's diseaseAn, Y. K., Allsop, S., Daveson, K.L. and Daveson, A. J. M. (2016). Demyelination during infliximab therapy for crown's disease. Australian Gastroenterology Week, Adelaide, SA, Australia, 10–12 October 2016. Richmond, VIC, Australia: Wiley-Blackwell Publishing Asia. doi: 10.1111/jgh.13522 |
|
2016 Conference Publication Nexvax2 (R), a Peptide-Based Antigen-Specific Immunotherapy, Administered Intra-Dermally Three-Times Over 15-Days attenuates Responsiveness to Immuno-Dominant Gluten Peptides in HLA-DQ2.5+People With Celiac Disease (CeD)Goel, Gautam, Andrews, Jane M., Krause, Richard, Fogel, Ron, Barish, Charles F., Daveson, A. J., Epstein, Roger, King, Tim, Kinney, Timothy, Krishnarajah, Janakan, Miner, Philip B., Tye-Din, Jason A., Girardin, Adam, Taavela, Juha, Popp, Alina, Maki, Markku, Goldstein, Kaela, Dzuris, John L., Williams, Leslie J., Xavier, Ramnik, Sollid, Ludvig M., Jabri, Bana and Anderson, Robert P. (2016). Nexvax2 (R), a Peptide-Based Antigen-Specific Immunotherapy, Administered Intra-Dermally Three-Times Over 15-Days attenuates Responsiveness to Immuno-Dominant Gluten Peptides in HLA-DQ2.5+People With Celiac Disease (CeD). 57th Annual Meeting and Residents Fellow Conference of the Society-for-Surgery-of-the-Alimentary-Tract (SSAT) / 52nd Annual Meeting on Digestive Disease Week (DDW) / Meeting of the American-Gastroenterological-Association (AGA), San Diego, California, United States, May 21-24, 2016. W B Saunders. |
|
2016 Conference Publication Efficacy, safety, tolerability and immunological effects of Nexvax2®, a peptide-based therapeutic vaccine, administered by intra-dermal (ID) injection twice –weekly for 8 weeks in HLA-DQ2.5+ celiac disease (CeD)Goel, Gautam, King, Tim, Daveson, A. J. M., Krishnarajah, Janakan, Brown, Gregor J., Tye-Din, Jason A., Girardin, Adam, Taavela, Juha, Popp, Alina, Maki, Markku, Goldstein, Kaela, Dzuris, John L., Williams, Leslie J., Xavier, Ramnik, Sollid, Ludvig M., Jabri, Bana and Anderson, Robert P. (2016). Efficacy, safety, tolerability and immunological effects of Nexvax2®, a peptide-based therapeutic vaccine, administered by intra-dermal (ID) injection twice –weekly for 8 weeks in HLA-DQ2.5+ celiac disease (CeD). 57th Annual Meeting and Residents Fellow Conference of the Society-for-Surgery-of-the-Alimentary-Tract (SSAT) / 52nd Annual Meeting on Digestive Disease Week (DDW) / Meeting of the American-Gastroenterological-Association (AGA),, San Diego, CA, United States, 21-24 May 2016. Maryland Heights, MO, United States: W.B. Saunders. |
|
2015 Conference Publication Polyp prevalence in patients aged 50 years or less: a prospective single centre analysisAl-Shinnag, M. and Daveson, J. A. (2015). Polyp prevalence in patients aged 50 years or less: a prospective single centre analysis. HOBOKEN: WILEY-BLACKWELL. |
|
2015 Conference Publication Concordance between numbers of duodenal biopsies collected at OGD and the number received for histological analysisTaylor, S. and Daveson, A. J. (2015). Concordance between numbers of duodenal biopsies collected at OGD and the number received for histological analysis. HOBOKEN: WILEY-BLACKWELL. |
|
2015 Conference Publication Video capsule endoscopy: can an Australian centre meet Capsule Endoscopy certification criteria for trainees?Lee, J. Y., Tutticci, N. and Daveson, A. J. (2015). Video capsule endoscopy: can an Australian centre meet Capsule Endoscopy certification criteria for trainees?. HOBOKEN: WILEY-BLACKWELL. |
|
2015 Conference Publication Pregnancy outcomes in patients with inflammatory bowel disease in a regional clinicAllsopp, S. and Daveson, A. J. (2015). Pregnancy outcomes in patients with inflammatory bowel disease in a regional clinic. HOBOKEN: WILEY-BLACKWELL. |
|
2015 Journal Article Appropriate clinical use of human leukocyte antigen typing for coeliac disease: an Australasian perspectiveTye-Din, J. A., Cameron, D. J. S., Daveson, A. J., Day, A. S., Dellsperger, P., Hogan, C., Newnham, E. D., Shepherd, S. J., Steele, R. H., Wienholt, L. and Varney, M. D. (2015). Appropriate clinical use of human leukocyte antigen typing for coeliac disease: an Australasian perspective. Internal Medicine Journal, 45 (4), 441-450. doi: 10.1111/imj.12716 |
|
2014 Conference Publication An Assessment of the Diagnostic Utility of Coeliac Serology in an Australian Referral CentreMuir, Richard, Smith, Ian and Daveson, A. James M. (2014). An Assessment of the Diagnostic Utility of Coeliac Serology in an Australian Referral Centre. 55th Annual Meeting of the Society-for-Surgery-of-the-Alimentary-Tract (SSAT) / Digestive Disease Week (DDW), Chicago Il, May 03-06, 2014. W B SAUNDERS CO-ELSEVIER INC. |
|
2013 Conference Publication Poor interlaboratory reliability of coeliac antibodies: An Australian and New Zealand perspective on the ESPGHAN guidelinesWienholt, L., Adelstein, S., Jovanovich, S., Steele, R., Tye-Din, J., Daveson, J. and Newnham, E. (2013). Poor interlaboratory reliability of coeliac antibodies: An Australian and New Zealand perspective on the ESPGHAN guidelines. The Australian Gastroenterology Week 2013, Melbourne, VIC Australia, 7 - 9 October 2013. Richmond, VIC 3121 Australia: Wiley-Blackwell Publishing Asia. doi: 10.1111/jgh.12365_7 |
|
2012 Journal Article Small bowel endoscopy and coeliac diseaseDaveson, A. James M. and Anderson, Robert P. (2012). Small bowel endoscopy and coeliac disease. Best Practice and Research: Clinical Gastroenterology, 26 (3), 315-323. doi: 10.1016/j.bpg.2012.03.004 |
|
2012 Journal Article Characterising the mucosal and systemic immune responses to experimental human hookworm infectionGaze, Soraya, McSorley, Henry J., Daveson, James, Jones, Di, Bethony, Jeffrey M., Oliveira, Luciana M., Speare, Richard, McCarthy, James S., Engwerda, Christian R., Croese, John and Loukas, Alex (2012). Characterising the mucosal and systemic immune responses to experimental human hookworm infection. PLoS Pathogens, 8 (2) e1002520, e1002520. doi: 10.1371/journal.ppat.1002520 |
|
2012 Conference Publication Outcomes post double balloon enteroscopy - a report of the first 57 casesAndelkovic, Melita, Jones, Dianne M. and Daveson, A. James M. (2012). Outcomes post double balloon enteroscopy - a report of the first 57 cases. Australian Gastroenterology Week 2012, Adelaide, SA Australia, 16-19 October 2012. Richmond, VIC Australia: Wiley-Blackwell. doi: 10.1111/j.1440-1746.2011.07251_4.x |
|
2012 Conference Publication Polyp prevalence at colonoscopy in patients aged 40 years or less: a prospective multisite analysisDaveson, A. James M., Jones, Dianne M. and Hewett, David G. (2012). Polyp prevalence at colonoscopy in patients aged 40 years or less: a prospective multisite analysis. Australian Gastroenterology Week 2012, Adelaide, SA, Australia, 16-19 October 2012. Richmond, VIC, Australia: Wiley-Blackwell. doi: 10.1111/j.1440-1746.2011.07251_3.x |
|
2011 Journal Article Suppression of inflammatory immune responses in celiac disease by experimental hookworm infectionMcSorley, Henry J., Gaze, Soraya, Daveson, James, Jones, Dianne, Anderson, Robert P., Clouston, Andrew, Ruyssers, Nathalie E., Speare, Richard, McCarthy, James S., Engwerda, Christian R., Croese, John and Loukas, Alex (2011). Suppression of inflammatory immune responses in celiac disease by experimental hookworm infection. PLoS One, 6 (9) e24092, e24092-1-e24092-7. doi: 10.1371/journal.pone.0024092 |
|
2011 Conference Publication A Phase 1 Study to Determine Safety, Tolerability and Bioactivity of Nexvax2 (R) in HLA DQ2+Volunteers With Celiac Disease Following a Long-Term, Strict Gluten-Free DietBrown, Gregor J., Daveson, James, Marjason, Joanne K., Ffrench, Rose A., Smith, Danielle, Sullivan, Mark, Tye-Din, Jason A. and Anderson, Robert P. (2011). A Phase 1 Study to Determine Safety, Tolerability and Bioactivity of Nexvax2 (R) in HLA DQ2+Volunteers With Celiac Disease Following a Long-Term, Strict Gluten-Free Diet. Conference on Digestive Disease Week 2011, Chicago Il, May 07-10, 2011. W B SAUNDERS CO-ELSEVIER INC. |
